TheChineTime

Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca - BioSpace

2026-03-24 - 13:30

Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca BioSpace

Share this post: